Anakinra versus placebo double blind Randomized controlled trial for the treatment of Acute MyocarditIS

Back

ESC Premium Access

Anakinra versus placebo double blind Randomized controlled trial for the treatment of Acute MyocarditIS

Session: Smaller trials, trial updates, and other studies on inflammation and immunity in cardiovascular disease

Topic: Myocarditis

Speaker: Professor M. Kerneis (Paris, FR)

Event: ESC Congress 2024

Congress Presentation

About the speaker

Professor Mathieu Kerneis

Pitie Salpetriere APHP University Hospital, Paris (France)

7 presentations

0 follower

7 more presentations in this session

Low-dose interleukin-2 for the reduction of vascular inflammation in acute coronary syndromes (IVORY) / IVORY - Clinical Outcomes And Follow-up (IVORY FINALE) Study

Speaker: Doctor R. Sriranjan (Cambridge, GB)

Access

Slides

Video

Colchicine for secondary prevention of stroke and other cardiovascular events: a meta-analysis of randomised trials

Speaker: Mr A. Fiolet (Utrecht, NL)

Access

Slides

Video

Cardiovascular benefit of colchicine in relation to baseline risk

Speaker: Mr N. Mohammadnia (Nijmegen, NL)

Access

Slides

Video

Effect of pre-hospital pulse-dose glucocorticoid on infarct size in st-segment elevation myocardial infarction: a randomized, blinded, placebo-controlled clinical trial

Speaker: Doctor J. Madsen (Copenhagen, DK)

Access

Slides

Video

Randomized double-blind trial to study the benefit of Colchicine in Patients with Acutely Decompensated Heart Failure

Speaker: Professor D. Pascual Figal (Murcia, ES)

Access

Slides

Video

Access the full session

Smaller trials, trial updates, and other studies on inflammation and immunity in cardiovascular disease

Speakers: Professor M. Kerneis, Doctor R. Sriranjan, Mr A. Fiolet, Mr N. Mohammadnia, Doctor J. Madsen...

Access

Video

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources